Morgan Lawrenz

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Morgan Lawrenz is an author at Schrodinger (United States) specializing in computational medicinal chemistry, pharmacy, and molecular property prediction.

ORCID

Publications per year

2023–2024

Publications

A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, K <sub>p,uu</sub>

Morgan Lawrenz, Mats Svensson, Mitsunori Kato et al. · Journal of Chemical Information and Modeling · 2023 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria Chemoprevention

Zhe Nie, Roger V. Bonnert, Jet Tsien et al. · Journal of Medicinal Chemistry · 2024 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

<i>In Silico</i> Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury

H. Rachel Lagiakos, Yefen Zou, Hideyuki Igawa et al. · Journal of Medicinal Chemistry · 2024 · 10 citations

Medicine, Medicinal Chemistry, Pharmacology +16

1–3 of 3